Official Course
Description: MCCCD Approval: 6-26-07 |
|||
DMI290
2007 Fall – 2009 Summer II |
LAB |
1.0 Credit(s) |
3.0 Period(s) |
Nuclear
Medicine Image Evaluation IV |
|||
Emphasis
on imaging of oncological disorders and
inflammatory processes. Evaluation of images related to clinical situations
and procedures including patient history, patient preparation, name and
energy of radiopharmaceutical, method of localization, dosimetry,
and method of clearance. Normal and abnormal distribution. Need for
additional views and/or procedures. Technical limitations, protocol and
equipment parameters and procedure results. Sectional human anatomy. Emphasis
on the thorax. |
|||
Go to Competencies Go to Outline
MCCCD
Official Course Competencies: |
|
|
|
DMI290 2007
Fall – 2009 Summer II |
Nuclear Medicine Image Evaluation IV |
1.
|
Explain the patient history and patient preparation for
imaging procedures of oncological disorders and
inflammatory processes. (I) |
2.
|
Select the appropriate radiopharmaceutical for imaging
procedures of specific oncological disorders and
inflammatory processes. (II) |
3.
|
State the name, energy, and method of localization, dosimetry, and method of clearance of an identified
radiopharmaceutical for a selected procedure. (II) |
4.
|
Describe the images of a selected procedure to include
normal distribution, abnormal distribution, artifacts, additional views,
additional procedures, any technical limitations either patient or equipment.
(III) |
5.
|
Identify technical limitations and corrective actions.
(IV) |
6.
|
Explain the imaging protocol for a selected procedure to
include indications, contraindications, and imaging procedure. (IV) |
7.
|
Set equipment parameters for equipment used. (V) |
8.
|
Identify anatomy in cross sectional views of the thorax.
(VI, VII, VIII, IX, X) |
Go to Description Go to top of
Competencies
MCCCD
Official Course Outline: |
||
|
||
DMI290 2007
Fall – 2009 Summer II |
Nuclear Medicine Image Evaluation IV |
|
|
||
I. Patient A. History B. Preparation II. Radiopharmaceutical A. Name B. Energy C. Method of localization D. Dosimetry
E. Method of clearance III. Procedure images A. Normal distribution B. Abnormal distribution C. Artifacts D. Additional views E. Additional procedures F. Technical limitations 1. Patient 2. Equipment IV. Procedure protocol A. Indications B. Contraindications C. Imaging procedure V. Equipment parameters A. Camera B. Collimator C. Computer set-up VI. Skeletal Thorax A. Apertures VII. Lungs A. Pleural cavities B. Bronchi VIII. Mediastinum
A. Thymus Gland B. Trachea and Esophagus IX. Lymphatic system A. Lymph nodes B. Lymph Vessels X. Heart and Vessels A. Landmarks B. Pericardium C. Heart wall D. Chambers E. Cardiac Valves F. Semilunar
Valves G. Branches of the Aortic
Arch H. Tributaries of the
Superior Vena Cava |
|
|